Evidence map›Paper›PMID 34643016›Full record

ArticleEuropean journal of cancer care2022

Clinician and patient experiences when providing and receiving information and support for managing chemotherapy-induced peripheral neuropathy: A qualitative multiple methods study.

Mary Anne Lagmay Tanay, Glenn Robert, Anne Marie Rafferty, Rona Moss-Morris, Jo Armes

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of cancer care, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.4field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Observational
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Mary Anne Lagmay TanayFlorence Nightingale Faculty of Nursing, Midwifery and Palliative Care, King's College London, London, UK.ORCID https://orcid.org/0000-0002-3637-6742
Glenn RobertFlorence Nightingale Faculty of Nursing, Midwifery and Palliative Care, King's College London, London, UK.
Anne Marie RaffertyFlorence Nightingale Faculty of Nursing, Midwifery and Palliative Care, King's College London, London, UK.
Rona Moss-MorrisInstitute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Jo ArmesSchool of Health Sciences, Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK.
King's College London · GBUniversity of Surrey · GB

Funding

National Institute for Health Research DRF-2018-11-ST2-017
6 · The paper itself

Abstract

objectiveTo improve patient experience of chemotherapy-induced peripheral neuropathy (CIPN), it is crucial to identify how patients develop their understanding and perception of CIPN. A wider understanding of the experiences of clinicians who provide CIPN information and support is also needed. This study explored clinician and patient experience of the provision of care, information and support for CIPN.

methodsData were collected between July and November 2019 using multiple qualitative methods. Non-participant observations were undertaken in colorectal and breast cancer clinics and at clinician stations, including the observation of chemotherapy consultations between patients and clinicians. Semi-structured interviews with people with cancer and clinicians were also conducted. Data were analysed using inductive reflexive thematic analysis.

resultsThree major themes emerged: (1) CIPN is a hidden chemotherapy side effect, (2) assessment and management of CIPN is disconnected and (3) patients and clinicians expect openness in CIPN symptom reporting, information provision and management.

conclusionFindings show the need to address the lack of patients' overall familiarity with CIPN. Echoing earlier studies, our findings suggest that knowledge and understanding about CIPN among clinicians are limited or lacking. These insights from patient and clinicians' CIPN experiences can inform future interventions that may address the genuine needs of patients and enhance CIPN support.

Indexed as

Antineoplastic AgentsBreast NeoplasmsPeripheral Nervous System DiseasesFemaleHumansPatient Outcome AssessmentAntineoplastic Agentscancerchemotherapychemotherapy-induced peripheral neuropathyCIPNqualitative

Identifiers

PMID34643016
PMCPMC9286565
OpenAlexW3204838485

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.